Free Trial

Grail Q2 2024 Earnings Report

Grail logo
$17.42 +0.01 (+0.06%)
As of 01/17/2025 04:00 PM Eastern

Grail EPS Results

Actual EPS
-$5.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Grail Revenue Results

Actual Revenue
$31.97 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Grail Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Grail Earnings Headlines

Grail reports cash balance of $767M, sees runway into 2028
Grail up 4% to $18.84 after guidance in conference presentation
HOTTEST TRADER IN AMERICA 🔥🔥🔥
Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Biosciences before it skyrocketed 2,269% in less than 24 hours…
See More Grail Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Grail? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Grail and other key companies, straight to your email.

About Grail

Grail (NASDAQ:GRAL) is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

View Grail Profile

More Earnings Resources from MarketBeat